Percutaneous transhepatic cholangiography (PTC) is a medical imaging technique used to diagnose and treat diseases of the biliary system, including gallstones, biliary strictures, and bile duct tumors. It is a minimally invasive procedure which involves the insertion of a needle into the liver to access the bile ducts for visualization. PTC can provide valuable information about the anatomy and function of the biliary system, which is essential for accurate diagnosis and treatment. In this article, we will discuss the basics of PTC, its indications, risks, and benefits.
Percutaneous transhepatic cholangiography (PTC) is a medical imaging technique used to diagnose and treat diseases of the biliary system. It involves the insertion of a needle through the skin into the liver to access the bile ducts for visualization. PTC is often used to diagnose and treat gallstones, biliary strictures, and bile duct tumors. The procedure is performed under local anesthesia and usually takes about 30 minutes to complete. During the procedure, a contrast material is injected into the bile ducts. This contrast material allows the doctor to see the bile ducts on an X-ray.
PTC is indicated in a number of situations. It is often used to diagnose and treat biliary strictures, which are narrowings of the bile ducts. It can also be used to diagnose and treat gallstones, which can cause pain and other symptoms. PTC can also be used to diagnose and treat bile duct tumors.
PTC is generally a safe procedure, but there are some risks associated with it. The most common risks include infection, bleeding, and damage to the bile ducts. There is also a risk of allergic reaction to the contrast material used during the procedure.
PTC can provide valuable information about the anatomy and function of the biliary system. This information is essential for accurate diagnosis and treatment. PTC can also be used to treat certain conditions, such as biliary strictures and gallstones. In addition, PTC is a minimally invasive procedure, which means it is less risky than more invasive procedures.
Percutaneous transhepatic cholangiography (PTC) is a medical imaging technique used to diagnose and treat diseases of the biliary system. It is a minimally invasive procedure which involves the insertion of a needle into the liver to access the bile ducts for visualization. PTC can provide valuable information about the anatomy and function of the biliary system, which is essential for accurate diagnosis and treatment. In addition, PTC can be used to treat certain conditions, such as biliary strictures and gallstones. Although there are some risks associated with PTC, it is generally a safe procedure with many benefits.
1.
Glioblastoma treatment breakthrough shows promise
2.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
3.
Study suggests exercise could reduce breast cancer recurrence
4.
Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus
5.
Daily physical activity, even at light intensities, linked to lower cancer risk
1.
Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer
2.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
3.
Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia
4.
HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians
5.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation